Please login or sign up to post and edit reviews.
Why Theranos’s blood-testing claims were always too good to be true
Podcast |
Science Weekly
Publisher |
The Guardian
Media Type |
audio
Podknife tags |
Interview
Science & Medicine
Categories Via RSS |
Science
Publication Date |
Jan 13, 2022
Episode Duration |
00:15:51
Last week, the tech CEO Elizabeth Holmes – once described as ‘the next Steve Jobs’ – was convicted of fraud, and could face decades in prison. Her now collapsed company, Theranos, promised to revolutionise medicine with a machine that could run hundreds of health tests on just a pinprick of blood. Those claims have since been exposed as false – but could they ever have been true? Madeleine Finlay speaks to the Guardian’s wealth correspondent, Rupert Neate, about Silicon Valley’s trial of the century, and pathologist Dr Benjamin Mazer about why Theranos’s vision seemed impossible from the start. Help support our independent journalism at theguardian.com/sciencepod
Last week, the tech CEO Elizabeth Holmes – once described as ‘the next Steve Jobs’ – was convicted of fraud, and could face decades in prison. Her now collapsed company, Theranos, promised to revolutionise medicine with a machine that could run hundreds of health tests on just a pinprick of blood. Those claims have since been exposed as false – but could they ever have been true? Madeleine Finlay speaks to the Guardian’s wealth correspondent, Rupert Neate, about Silicon Valley’s trial of the century, and pathologist Dr Benjamin Mazer about why Theranos’s vision seemed impossible from the start. Help support our independent journalism at https://www.theguardian.com/sciencepod">theguardian.com/sciencepod

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review